BIOT.US Instinct Bio Technical Company Holdings Inc. Ordinary Shares
- Market cap
- USD 5.47M
- P/E
- -
- P/B
- 2.70x
- ROE
- 3.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Nov 2024.
Is BIOT.US undervalued?
Graham numberThe Graham number of Instinct Bio Technical Company Holdings Inc. Ordinary Shares cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Instinct Bio Technical Company Holdings Inc. Ordinary Shares fundamental analysis
No fundamental analysis for Instinct Bio Technical Company Holdings Inc. Ordinary Shares yet.
Instinct Bio Technical Company Holdings Inc. Ordinary Shares stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Instinct Bio Technical Company Holdings Inc. Ordinary Shares
Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution. It has a strategic collaboration with PT Parva Candela to develop cosmetics business in Indonesia. The company was founded in 2011 and is headquartered in Tokyo, Japan.
Full company profileInstinct Bio Technical Company Holdings Inc. Ordinary Shares financial statements
Instinct Bio Technical Company Holdings Inc. Ordinary Shares annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 |
|---|---|---|
| Income Statement | ||
| Revenue | 3.43M | 2.76M |
| Gross Profit | 2.98M | 2.00M |
| Operating Income | 399K | -67.9K |
| EBITDA | 817K | 367K |
| Net Income | 545K | 74.7K |
| Balance Sheet | ||
| Total Assets | 3.42M | 3.11M |
| Total Liabilities | 1.11M | 768K |
| Shareholders' Equity | 2.31M | 2.34M |
| Cash & Short-term Investments | 240K | 512K |
| Cash Flow | ||
| Operating Cash Flow | -978K | 590K |
| Capital Expenditure | 70.3K | 26.8K |
| Free Cash Flow | -1.05M | 563K |
| Ratios | ||
| ROE | 23.6% | 3.2% |
| ROA | 15.9% | 2.4% |
| Net Profit Margin | 15.9% | 2.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Instinct Bio Technical Company Holdings Inc. Ordinary Shares dividends
Instinct Bio Technical Company Holdings Inc. Ordinary Shares has not paid dividends in the last 2 fiscal years.
Who owns Instinct Bio Technical Company Holdings Inc. Ordinary Shares
- Insiders 12.19%
- Institutions 6.13%
- Public & others 81.68%
- Shares outstanding 28.8M
Instinct Bio Technical Company Holdings Inc. Ordinary Shares company profile
- Company name
- Instinct Bio Technical Company Holdings Inc. Ordinary Shares
- Ticker
- BIOT.US
- Exchange
- USA Stocks
- Listed since
- Jul 24, 2026
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Fiscal year end
- November
- Address
- , Tokyo, Japan
- Website
- instinct-biot.com
About Instinct Bio Technical Company Holdings Inc. Ordinary Shares
Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution. It has a strategic collaboration with PT Parva Candela to develop cosmetics business in Indonesia. The company was founded in 2011 and is headquartered in Tokyo, Japan.
Instinct Bio Technical Company Holdings Inc. Ordinary Shares management
7- Mr. Tomoki NaganoFounder, Group Chairman & CEO · born 1981
- Mr. Masashi OhmatsuChief Financial Officer · born 1962
- Mr. Yuji NaitoSenior Executive Managing Director, Director & COO · born 1979
- Mr. Fumihiro NaganoChief Marketing Officer & Representative Director · born 1978
- Mr. Futa Sakakibara Ph.D.Chief Technical Officer
- Takashi BodaHead of Sales, Head of Value Athlete Division & Executive Officer
- Kenta NakajimaHead of Manufacturing (Japan & International) and Executive Officer